First Patient Dosed in the Phase 1/2 Study of BEAM-301 in Glycogen Storage Disease Type Ia, Beam's Second Clinical Stage In Vivo Editing Program Updated Data from BEACON Phase 1/2 Clinical Trial of BEAM-101 Accepted for Presentation at the European Hematology Association 2025 Congress in June Following Positive Initial Data for BEAM-302 in Alpha-1 Antitrypsin Deficiency, Company Initiated Dosing of Fourth Cohort in Part A of Phase 1/2 Trial and Received Clearance of U.S. IND; Updated Data Expected to be Presented in Second Half of 2025 Ended First Quarter 2025 with $1.2 Billion in Cash, Cash Equivalents and Marketable Securities, …

License Expands Genprex's Portfolio of Oncology Gene Therapy Technologies AUSTIN, Texas , May 6, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced it has entered into an exclusive patent license agreement with UTHealth Houston granting Genprex exclusivity and commercial rights relating to its lead drug candidate, Reqorsa® Gene Therapy (quaratusugene ozeplasmid) for the potential treatment of glioblastoma. The subject patent is co-owned by Genprex and UTHealth Houston, and the license provides Genprex with patent exclusivity.

AEP completes anticipated equity needs to execute five-year, $54 billion capital investment plan. Company makes progress achieving balanced regulatory outcomes, focuses on needs of states.

First Quarter Adjusted EBITDA Exceeds Upper-End of Guidance Range Reiterates 2025 Outlook Net sales were $792.0 million, and adjusted net sales1 were $796.0 million. Net loss was $(31.8) million.

I believe Veeva's robust product roadmap, including the introduction of Veeva AI, should deepen adoption and drive productivity across its Development and Commercial Cloud segments. Despite a projected revenue growth slowdown in FY26, Veeva's management remains confident in achieving its $6B revenue target by 2030. VEEV's strong financial discipline is evident, with non-GAAP operating margins expected to expand to 43% in FY26 despite a projected revenue slowdown.

It's hard to find optimists these days, but money manager Matt Shapiro is among them, and he says if investors can look past the turmoil, there's plenty of opportunity in this market.

CORVALLIS, Ore.--(BUSINESS WIRE)--NuScale Power announced that its management is scheduled to participate in several institutional investor conferences in May and June 2025.

GREENSBORO, N.C.--(BUSINESS WIRE)---- $KTB--Kontoor Brands, Inc. (NYSE: KTB), a global lifestyle apparel company, with a portfolio led by two of the world's most iconic consumer brands, Wrangler® and Lee®, today reported financial results for its first quarter ended March 29, 2025. “Our strong first quarter results reflect the operational agility that is a cornerstone of our business,” said Scott Baxter, President, Chief Executive Officer and Chairman of the Board of Directors. “We continued to strength.

Net sales of $662.9 million driven by organic growth of 1.4%, offset by currency headwinds of 1.7%, resulting in the fourth consecutive quarter of organic revenue growth.1 Gross margin for the second quarter was 39.1% and 40.8% as adjusted, a 30 bps improvement over prior year Adjusted Gross margin.1 Delivered Net Earnings of $28.3 million, or $0.39 per share, Adjusted Earnings per share of $0.67 and Adjusted EBITDA of $140.3 million.1 The Company expects limited direct impact from tariffs to fiscal 2025 results due to already completed sourcing shifts and pricing actions. The Company expects a more cautious consumer over …

VANCOUVER, BC / ACCESS Newswire / May 6, 2025 / Skeena Resources Limited (TSX:SKE)(NYSE:SKE) ("Skeena Gold & Silver", "Skeena" or the "Company") today published its 2024 Sustainability Report, offering stakeholders an update on its sustainable development activities and performance. The report highlights Skeena's environmental, social and ethical business practices, as well as the significant economic benefits that Eskay Creek ("Eskay" or the "Project") will deliver to Indigenous Nations, the province of British Columbia and Canada.

Roy Jakobs, CEO of Philips, discusses the efforts the Dutch health technology firm is taking to mitigate the tariff impact from the United States, from localizing supply chains to "decisive cost actions."

“Another year is off to a great start” said Benedetto Vigna, CEO of Ferrari. “In the first quarter of 2025, with very few incremental shipments year on year, all key metrics recorded double-digit growth, underscoring a strong profitability driven by our product mix and continued demand for personalizations. This confirms – once again – our strategy of ‘quality of revenues over quantity'. We continue to enrich our product offering – in line with our plans – with six new models this year, which include the newly launched 296 Speciale, 296 Speciale A and the much-anticipated Ferrari elettrica through a unique …

Wall Street soared last week as strong jobs data and easing trade tensions sparked market optimism. HIMS, BOIL, RGTX, NVOX, and MSFL were the top-performing leveraged ETFs last week.

HMY and OSPN made it to the Zacks Rank #1 (Strong Buy) value stocks list on May 6, 2025.

Tim Richards, founder and CEO of Vue, discusses the potential impact of U.S. President Donald Trump's movie tariffs on the European film industry.

First quarter sales declined 3.6% to $1.23 billion Installation sales declined 6.7%, offset in part by Specialty Distribution growth of 2.6% Delivered adjusted gross margin of 29.6% and adjusted EBITDA margin of 19.0% DAYTONA BEACH, Fla., May 06, 2025 (GLOBE NEWSWIRE) -- TopBuild Corp. (NYSE:BLD) a leading installer and specialty distributor of insulation and building material products to the construction industry in the United States and Canada today reported results for the first quarter ended March 31, 2025.

MANAUS, Brazil, May 06, 2025 (GLOBE NEWSWIRE) -- Brazil Potash Corp. (“Brazil Potash” or the “Company”) (NYSE American: GRO), a mineral development company with a critical mineral potash mining project, today announced that it has entered into a definitive agreement establishing an equity line of credit (“ELOC”) with Alumni Capital LP (“Alumni”), an institutional investor. Brazil Potash anticipates that this agreement will provide the company with a flexible source of funding, enabling the Company to progress its flagship Autazes Potash Project.

Delivered Net Sales and Profitability within Guidance Range Drove 12% Y/Y Growth in Total Orders and 13% Y/Y Growth in Repeat Orders Q1 2025 GAAP Diluted EPS of $(0.03) and Adjusted Diluted EPS of $0.00 Reiterates Annual Guidance and Provides Q2 Outlook

Backlog Grows by 20% Year-Over-Year with TTM Book-to-Bill Ratio of 1.3x Repurcha sed $351 Million of Jacobs Shares During Q2 and $552 Million in First Half of FY25 Exited Company's Retained Stake in AMTM and Announced May 30th Distribution of Remaining Shares Reaffirming FY 2025 Guidance DALLAS , May 6, 2025 /PRNewswire/ -- Jacobs Solutions Inc. (NYSE: J) today announced its financial results for the fiscal second quarter ended March 28, 2025. Q2 2025 Highlights1: Gross revenue of $2.9 billion grew 2.2% y/y; adjusted net revenue2 up 3.1% y/y Revenue and profit adversely impacted by a reserve following an interim …

THE WOODLANDS, Texas , May 6, 2025 /PRNewswire/ -- Target Hospitality Corp. ("Target Hospitality", "Target" or the "Company") (NASDAQ: TH), one of North America's largest providers of vertically integrated modular accommodations and value-added hospitality services, today announced that it will attend and present at the Oppenheimer 20th Annual Industrial Growth Conference on Wednesday, May 7, 2025. Presentation Details Oppenheimer 20th Annual Industrial Growth Conference Date: Wednesday, May 7, 2025 Time: 3:00 pm Eastern Time (2:00 pm Central Time) The event will be broadcast live via webcast.